The Flt3 receptor tyrosine kinase and its ligand Flt3l regulate dendritic cell development in the steady state [1] [2] [3] [4] [5] [6] . Flt3 is first expressed in multipotent hematopoietic progenitors (CD150 − Flt3 + ) that develop into lymphoid and myeloid cells 7, 8 , but expression is lost by all lineages except dendritic cells during development.
The Flt3 receptor tyrosine kinase and its ligand Flt3l regulate dendritic cell development in the steady state [1] [2] [3] [4] [5] [6] . Flt3 is first expressed in multipotent hematopoietic progenitors (CD150 − Flt3 + ) that develop into lymphoid and myeloid cells 7, 8 , but expression is lost by all lineages except dendritic cells during development.
In the steady state, dendritic cell development proceeds from precursors, which give rise to monocytes and dendritic cells (MDPs) 4, 9 , to common dendritic cell progenitors, which lack monocyte potential (CDPs) 5, 6, 10, 11 and give rise to circulating predendritic cells [11] [12] [13] . All of these cell types are dependent on Flt3l in the steady state. During inflammation, pattern recognition receptors, such as TLRs, RIGlike helicases and the inflammasome, mediate pathogen sensing and induce the maturation of differentiated dendritic cells, a process that controls the initiation of immune responses. However, little is known about the mechanisms that regulate the development of dendritic cells in response to infection and microbial innate sensing.
In this report we examine how the dendritic cell pathway is regulated during acute malaria infection. We find that Plasmodium infection is associated with increased serum concentrations of FLT3L and increased dendritic cell production in both mice and humans.
Moreover, dendritic cell expansion in response to Plasmodium infection requires FLT3L, which mostly affects the CD8-α + dendritic cell subset in mice and the BDCA3 + dendritic cell subset in humans. We identify mast cells as an important source of this FLT3L in mice and show that they produce it in response to uric acid accumulation. This response is facilitated by TLR9-dependent type I IFN induction of xanthine dehydrogenase, which promotes hyperuricemia during Plasmodium infection. Ultimately, the dendritic cells induced by inflammatory FLT3L help activate T cell responses to the parasites.
RESULTS

Flt3l and dendritic cell increase during Plasmodium infection
To examine dendritic cell regulation during Plasmodium infection, we infected C57BL/6 mice with blood-stage P. chabaudi and measured Flt3l [1] [2] [3] . We found that the amounts of soluble Flt3l increased from 300 (baseline) to 1,000 pg ml −1 in the serum of these mice by as early as day 2 after infection and remained elevated up to 6 d after infection (Fig. 1a) . Consistent with previous reports 14, 15 , we found that spleen dendritic cells (DEC205 + CD8-α + and 33D1 + CD8-α − ) underwent transient contraction and then expansion (Fig. 1b-d and Supplementary Fig. 1a,b) . To determine whether dendritic cell expansion during P. chabaudi infection was dependent on Flt3l and its receptor Flt3, we infected wild-type (WT), Flt3 −/− (ref. 16 ) and Flt3l −/− (ref. 1) mice and quantified the dendritic cells in their spleens at day 7 after infection ( Fig. 1c,d) . As previously noted, the absolute numbers of both subsets of spleen dendritic cells were reduced in uninfected Flt3 −/− (ref. 4) and Flt3l −/− mice 1 . In addition, dendritic cell populations that expanded in infected mice, especially CD8-α + dendritic cells, remained dependent on Flt3 and Flt3l (Fig. 1c,d) .
To determine which aspect of dendritic cell development is dependent on Flt3 during P. chabaudi infection, we analyzed dendritic cell progenitors in the bone marrow. The hematopoietic stem cell (HSC)-containing fraction (Lin − CD117 (c-Kit) high Sca-1 + ) underwent a progressive expansion as early as 2 d after infection ( Fig. 1e and Supplementary Fig. 2a ) 17 . Both the Lin − CD117 high Sca-1 + CD150 + and CD150 − subsets expanded, but only Flt3-expressing CD150 − cells were regulated by Flt3 ( Fig. 1f and Supplementary Fig. 2b ) 7, 8 . Similarly to dendritic cells in the periphery, MDPs and CDPs underwent a transient contraction followed by an expansion in infected mice, which we determined by analyzing Lin − CD117 + Sca-1 − CD115 + cells 4, 9, 10 ( Fig. 1g and Supplementary Fig. 2c) . Notably, the infectioninduced expansion of MDPs and CDPs was compromised in Flt3 −/− and Flt3l −/− mice ( Fig. 1h and Supplementary Fig. 2d ), demonstrating that the entire dendritic cell developmental pathway responds to infection by a Flt3-dependent mechanism.
Role of CD8-a + dendritic cells during Plasmodium infection
We used langerin-DTR mice to deplete CD8-α + and CD103 + dendritic cells 18, 19 , which we found is the subset most affected by an acute increase in Flt3l release during infection (Fig. 2a) . P. chabaudi infection triggers activation of both CD4 + and CD8 + T cells, as measured by CD44 high CD62L low effector and memory T cells 7 d after infection (Fig. 2b-g ). Depletion of spleen CD8-α + and CD103 + dendritic cells did not modify the percentage of activated CD4 + T cells in the spleen (Fig. 2b,c) or their phenotype (Supplementary Fig. 3d ) but did reduce their numbers (Fig. 2d) . In contrast, depletion of CD8-α + and CD103 + dendritic cells impaired CD8 + T cell activation, both in the percentage and absolute number of activated cells (Fig. 2e-g ). We conclude that Flt3l-regulated CD8-α + dendritic cells support T cell responses most crucially in the CD8 + T cell compartment. Depletion of CD8-α + and CD103 + dendritic cells increased parasitemia and compromised survival to P. chabaudi infection (Supplementary Fig. 3a-c) .
In contrast to P. chabaudi 20 , CD8 + T cell responses to the ANKA strain of P. berghei induce lethal brain immunopathology [21] [22] [23] . Depletion of CD8-α + and CD103 + dendritic cells during P. berghei ANKA infection in langerin-DTR mice delayed lethality without affecting parasitemia (Supplementary Fig. 4a ) and reduced brain pathology (Supplementary Fig. 4b ) and CD8 + T cell accumulation in the brain (Supplementary Fig. 5a ). We found similar results in Flt3l −/− mice (Supplementary Fig. 6 ). We conclude that Flt3l-regulated CD8-α + and CD103 + dendritic cells are required for the severity of CD8 + T cell-dependent brain immunopathology during infection with P. berghei ANKA.
Mast cells release Flt3l in response to Plasmodium infection
To determine the source of inflammatory Flt3l, we produced reciprocal bone marrow chimeras between WT and Flt3l −/− mice (Fig. 3a) . Analysis revealed that the increase in serum Flt3l concentration in response to P. chabaudi infection was dependent on the radioresistant compartment. Lethally irradiated Flt3l −/− recipients of WT or Flt3l −/− bone marrow were defective in their serum Flt3l responses to P. chabaudi infection, whereas WT recipients of WT or Flt3l −/− bone marrow were not (Fig. 3a) . We conclude that a radioresistant cell type releases Flt3l during P. chabaudi infection.
Analysis of an expression database (http://biogps.gnf.org) indicated that radioresistant 24 mast cells constitutively express high levels of Flt3l (Supplementary Fig. 7) . To analyze the potential contribution of mast cells to the increase in Flt3l concentration, we analyzed the membrane-bound precursor of Flt3l on bone marrow-derived mast cells (BMMCs) before and after degranulation ( Supplementary  Fig. 8 ). Mast cell degranulation (probed by lysosomal-associated membrane protein 1 (Lamp1) upregulation) decreased the surface amounts of Flt3l, whereas the amount of soluble Flt3l increased markedly in culture supernatants (Supplementary Fig. 8 ). Thus, BMMCs express the Flt3l precursor, which is released as a soluble cytokine after degranulation. To address the relevance of this process in vivo, we measured serum Flt3l concentrations after degranulation of mast cells triggered by the high-affinity IgE receptor FcεRI (Supplementary Fig. 9a-d) . Naive peritoneal mast cells express high levels of membrane-bound Flt3l (Supplementary Fig. 9a ), but other immune cells do not (Supplementary Fig. 9b ). After administration of antibodies to IgE, mast cells degranulate (determined by Lamp1 upregulation) and show decreased amounts of cell surface Flt3l (Supplementary Fig. 9a ). Concomitantly, Flt3l serum concentrations increased rapidly in mice treated with antibodies to IgE but not mast cell-deficient Kit W-sh mice 25 or control immunoglobulin-treated mice ( Supplementary Fig. 9c,d) . We conclude that mast cells constitutively show cell surface Flt3l and mast cell degranulation triggers the release of soluble Flt3l.
We next examined peritoneal mast cells from P. chabaudi-infected mice. The mast cells underwent degranulation, as measured by increased amounts of surface Lamp1 (Supplementary Fig. 9e ) and decreased amounts of membrane Flt3l (Fig. 3b,c) concomitant with an increase in the amount of serum Flt3l (Figs. 1a and 3d) . Furthermore, the increase in serum Flt3l in response to P. chabaudi (and P. berghei ANKA) was dependent on mast cells, as it was nearly absent in mast cell-deficient Kit W-sh mice 25 despite normal amounts of steady-state Flt3l ( Fig. 3d and Supplementary Fig. 9f ). We conclude that mast cells are activated during malaria infection and release membrane Flt3l into the circulation.
To determine whether mast cells are required for the increase in dendritic cell numbers during malaria infection, we analyzed spleen dendritic cell populations in mast cell-deficient Kit W-sh mice ( Fig. 3e-g ). Although the steady-state numbers of CD8-α + dendritic cells were similar in WT and Kit W-sh mice, the numbers of CD8-α + (but not CD8-α − ) dendritic cells did not increase in the spleens of P. chabaudi-infected Kit W-sh mice ( Fig. 3e-g ). Notably, administration of recombinant Flt3l to P. chabaudi-infected Kit W-sh mice restored CD8-α + dendritic cell expansion (Fig. 3e,f) , showing that the Kit W-sh mutation does not impair dendritic cell responsiveness to Flt3l. Mast cell deficiency also led to a significant impairment in CD8 + T cell activation (Fig. 3h,i ) but had no effect on CD4 + T cells (Fig. 3j) . This defect was circumvented by administration of recombinant Flt3l, thereby excluding a defect in Kit W-sh CD8 + T cells. Taken together, these results show that mast cells promote CD8 + T cell activation by controlling Flt3l serum concentrations and the expansion of CD8α + dendritic cells in the spleen during P. chabaudi infection.
Uric acid triggers Flt3l release from mast cells P. chabaudi infection might induce Flt3l release from mast cells by innate signaling pathways activated by parasite-sensing such as inflammasome-dependent cytokines (interleukin-1 (IL-1) and IL-18) or ATP-sensing receptor P2 X 7R. We found no evidence that these pathways mediated Flt3l release from mast cells ( Supplementary  Fig. 10a-c ). An alternative possibility is that mast cell activation is ) are shown as the mean ± s.e.m. **P < 0.01, ***P < 0.001 determined by t test. NS, not significant. npg mediated directly by uric acid. It has been shown in vitro that hypoxanthine released from Plasmodium-infected red blood cells can be converted to uric acid by phagocyte-derived xanthine dehydrogenase 26, 27 (Xdh), and uric acid crystals can in turn be sensed by various immune cells through a mechanism that requires direct activation of spleen tyrosine kinase (Syk) [28] [29] [30] . To test the possibility that uric acid induces Flt3l, we injected mice with uric acid crystals (Fig. 4a-c) . Whereas serum Flt3l concentrations increased rapidly after the injection, mast cells showed decreased amounts of membrane-bound Flt3l (Fig. 4a-c) . Control allopurinol crystals had no effect on mast cell activation (Supplementary Fig. 11a ). By contrast, oxonic acid, a specific inhibitor of uricase (inducing hyperuricemia in vivo), also increased serum Flt3l concentrations (Supplementary Fig. 11b) . We conclude that uric acid induces rapid increases in circulating Flt3l through mast cell activation.
To determine whether uric acid triggers mast cell release of Flt3l during Plasmodium infection, we measured serum uric acid concentrations during P. chabaudi infection (Fig. 4d) . We found that P. chabaudi infection, but not control injection (Supplementary Fig. 11c ), induced transient hyperuricemia, which is also a hallmark of experimental cerebral malaria in mice 31, 32 and of severe malaria in humans 33, 34 . To test the contribution of uric acid to serum Flt3l responses, we blocked uric acid accumulation by administration of allopurinol (an inhibitor of Xdh) and uricase (Supplementary Fig. 11d) . Consistent with the idea that uric acid triggers Flt3l release from mast cells, Flt3l serum concentrations were significantly decreased in treated mice (Fig. 4e) . Mast cell activation was also decreased (determined by Lamp1 exposure and Flt3l release; Fig. 4f ). Uric acid inhibition also led to a significant decrease in CD8-α + dendritic cell expansion in the spleens of P. chabaudi-infected mice (Fig. 4g) and CD8 + T cell activation (day 8; Fig. 4h) . We conclude that uric acid participates in mast cell activation and Flt3l release during malaria infection, which results in dendritic cell expansion and promotes T cell activation.
Type I IFN and uric acid production during Plasmodium infection TLRs are important in the innate sensing of Plasmodium parasites [35] [36] [37] [38] . We found that Myd88 −/− Ticam1 −/− (note that Ticam1 npg is also known as Trif) double knockout mice, Myd88 −/− mice and Tlr9 −/− mice, but not Ticam1 −/− mice, had an impaired Flt3l response to P. chabaudi blood-stage infection (Fig. 5a ). In accordance with TLR9 involvement [35] [36] [37] [38] , we found that P. chabaudi infection triggers a transient and systemic IFN-α response that was fully abrogated in Myd88 −/− Ticam1 −/− double knockout mice (Fig. 5b) (and in mice lacking plasmacytoid dendritic cells; Supplementary Fig. 12a,b) . Mice deficient in type I IFN receptor (Ifnar1 −/− ) did not produce a systemic increase in the amount of Flt3l in response to infection with P. chabaudi (Fig. 5c) or P. berghei ANKA (Supplementary Fig. 12c) . However, this effect was indirect, as type I IFN did not induce Flt3l secretion from BMMCs ( Supplementary Fig. 10a,b) , and the cells that required type I IFN receptor were radiosensitive cells (Fig. 5d) , which are not the main source of inflammatory Flt3l (Fig. 3a) . As uric acid sensing participates in mast cell activation and Flt3l release during Plasmodium infection (Fig. 4) , we asked whether type I IFN signaling was involved in regulating uric acid production. To test this possibility, we measured the uric acid-producing enzyme Xdh. We found that Xdh mRNA, its enzymatic activity and lung uric acid concentrations (Fig. 5e) were highly upregulated in the first day after infection with P. chabaudi or P. berghei ANKA ( Supplementary  Fig. 12d ) in a manner that was dependent on Ifnar1. Consistent with the role of uric acid in triggering mast cell activation and Flt3l release (Fig. 4) , we found that mast cell activation was impaired in Ifnar1 −/− mice, both in terms of Lamp1 exposure and Flt3l release (Fig. 5f) 
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( Fig. 5g) and Myd88 −/− Ticam1 −/− mice (Supplementary Fig. 13a ) showed impaired CD8-α + dendritic cell expansion in the spleen in response to P. chabaudi infection despite normal responsiveness to recombinant Flt3l (Supplementary Fig. 13b ). CD8 + , but not CD4 + , T cell activation was also impaired in Ifnar1 −/− mice (Fig. 5h) . We conclude that type I IFN signaling downstream of TLR-dependent type I IFN secretion controls Xdh production by radiosensitive cells. This acute increase in Xdh synthesis supports uric acid production, which in turn induces mast cells to release Flt3l in response to Plasmodium infection (Supplementary Fig. 14) .
FLT3L release supports BDCA3 + dendritic cell expansion
Severe human malaria is associated with increased numbers of circulating BDCA3 + dendritic cells 39 , which correspond to mouse CD8-α + dendritic cells 18, [40] [41] [42] . To determine whether FLT3L is elevated in humans infected with P. falciparum, we measured the amounts *** of this growth factor in the blood of Kenyan children with mild or severe malaria. FLT3L was not detectable in the serum of age-matched uninfected controls (n = 47) but was present in n = 5/27 cases of mild malaria and n = 32/92 cases of severe malaria (Fig. 6a) . The increase in FLT3L plasma concentration with increasing disease severity was statistically significant (Kruskal-Wallis test P < 0.0001). For a subgroup of patients, we had previously determined the frequency of peripheral blood dendritic cell subsets 39 .
Myd88
Patients with detectable amounts of FLT3L in plasma had elevated frequencies of circulating BDCA3 + but not BDCA1 + or BDCA2 + dendritic cells (Fig. 6b-d) .
To determine whether human FLT3L increases the numbers of circulating BDCA3 + dendritic cells, we analyzed the effect of human FLT3L administration in mice reconstituted with human HSCs (Fig. 6e,f and Supplementary Fig. 15a ). We found that FLT3L administration was sufficient to induce an increase in the human dendritic cell compartment in the blood (Fig. 6e) and spleen (Fig. 6f) . Notably, the effect was more pronounced in the BDCA3 + dendritic cell subset in both the blood and spleen compartments (Fig. 6e,f and  Supplementary Fig. 15b) .
To determine whether the increased amounts of FLT3L and dendritic cells are also associated with enhanced amounts of CD8 + T cell activation in infected individuals, we analyzed T cell activation status by measuring CD69 expression levels by flow cytometry. We found that as compared to FLT3L-negative patients, FLT3L-positive patients showed a similar proportion of activated CD4 + T cells (Fig. 6g) (Fig. 6h) . We conclude that the host response to human malaria includes a systemic increase in the amount of FLT3L, BDCA3 + dendritic cell expansion and CD8 + T cell activation.
DISCUSSION
Here we demonstrate that innate sensing by mast cells during Plasmodium infection leads to a systemic elevation of the amount of Flt3l, which affects host responses to the parasite by increasing the number of dendritic cells and promoting T cell activation.
Flt3l is an essential growth factor for dendritic cells in vitro and in vivo 1, 4, 43 that can have tolerogenic effects in the absence of systemic inflammation 44, 45 . During mouse cytomegalovirus infection, Flt3l production is upregulated 46 . We have shown that Flt3l concentrations in serum also increase in response to P. chabaudi and P. berghei ANKA infections in mice and to P. falciparum infection in humans. Having found that inflammatory Flt3l originates from the radioresistant compartment, we identified radioresistant mast cells as major producers of soluble Flt3l.
Mast cells and their products have been implicated in regulating dendritic cells 47, 48 . The release of pre-synthesized TNF-α by mast cells during inflammation promotes dendritic cell maturation and migration from the skin to lymph nodes [47] [48] [49] . Our experiments uncover a previously unappreciated TNF-α-independent role for mast cells in regulating serum Flt3l concentrations and dendritic cell populations during inflammation. Mast cells express high levels of membrane Flt3l, which is rapidly released into the circulation after degranulation, resulting in preferential expansion of CD8-α + CD103 + dendritic cells. This new function for activated mast cells in adaptive immunity is complementary to their role in dendritic cell migration [47] [48] [49] and downregulation of regulatory T cell function 50 .
Our experiments show that Flt3l release by radioresistant mast cells in response to Plasmodium infection requires type I IFN signaling by radiosensitive cells. Type I IFN is produced in response to TLR9 and Myd88 sensing during Plasmodium infection [35] [36] [37] [38] . Moreover, mice deficient for the type I IFN receptor or for TLRs show an impaired immune responses to P. chabaudi infection 36 and are more resistant to P. berghei immunopathology 51, 52 . Type I IFN mediates most of its effects on Flt3l indirectly by acting on the radiosensitive compartment. Type I IFN induces Xdh, an enzyme that converts the hypoxanthine and xanthine that accumulate in Plasmodium-infected erythrocytes to uric acid 26, 27 . The radiosensitive cells mediating these effects remains to be identified. In addition, uric acid can also precipitate inside infected red blood cells, providing an inflammatory stimulus for upregulation of CD80 and CD86 and downregulation of MHC II in dendritic cells 30 . Uric acid, released from dead cells 36 or Plasmodium-infected erythrocytes 26, 27, 30 , is known to be proinflammatory, and hyperuricemia is a hallmark of malaria infection 31, 32 , including severe malaria in humans 33, 34 . Our experiments reveal that, in addition to direct dendritic cell activation 29, 30, 53 , uric acid contributes to Flt3l release from mast cells, leading to increased numbers of dendritic cells.
In mice, the CD8-α + CD103 + subset is sensitive to acute increases in serum Flt3l concentrations. This phenomenon is mirrored by the increase of their human equivalent, BDCA3 + dendritic cells 18, [40] [41] [42] , in the circulation during P. falciparum infection 39 . Although only limited data were available for infected children, we confirmed the association between increased amounts of FLT3L and increased numbers of human BDCA3 + dendritic cells using mechanistic experiments in humanized mice showing that FLT3L alone is able to preferentially increase the number of circulating BDCA3 + dendritic cells.
Despite the toxic effects of infection on dendritic cells 54 , dendritic cell function is relevant for protective immunity to Plasmodium blood-stage infection 55 . Experiments with CD11c-DTR mice in which CD11c-expressing cells were depleted with diphtheria toxin show that these cells are essential for protective immunity to Plasmodium yoelii pre-erythrocytic stages 56 and for induction of experimental cerebral malaria in mice infected with the blood stage of P. berghei ANKA 57 . Our experiments with langerin-DTR mice show that the loss of CD8-α + CD103 + dendritic cells, which are acutely responsive to inflammatory Flt3l, results in impaired CD8 + T cell activation 19, 58, 59 . In addition, the same CD8-α + CD103 + dendritic cell subset is essential to induce the pathogenic CD8 + T cells that are responsible for lethal brain inflammation during P. berghei ANKA infection. We also show that the proportion of activated CD8 + T cells (but not CD4 + T cells) in the peripheral blood correlates with the magnitude of the Flt3l response in P. falciparum infection in severe malaria.
Taken together, our data uncover a Flt3l-dependent pathway that regulates dendritic cell development and T cell activation during infection.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
